Skip to content
2000
Volume 13, Issue 2
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

Platinum complexes such as cisplatin and caboplatin are widely used in cancer chemotherapy. However, their clinical applications are substantially limited by unexpected toxic side effects. In this review, we discuss the current progress on the design and synthesis of estradiol-linked platinum complexes as the targeted antitumor drugs. Many of them display a high antitumor activity against the growth of breast cancer cell lines in vitro. The estradiol-linked platinum complexes could be used as target therapeutics for breast cancer.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/138955713804805247
2013-02-01
2025-09-04
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/138955713804805247
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test